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Ressonância magnética nuclear de 1H de alta resolução com giro no ângulo mágico 
(HR-MAS NMR) é uma técnica empregada na avaliação de células e tecidos intactos. Entretanto, 
parâmetros bem estabelecidos de NMR são cruciais para a obtenção de resultados confiáveis. A 
fim de discutir as principais etapas envolvidas na otimização das análises de HR-MAS NMR, este 
artigo avaliou diferentes sequências de pulsos e parâmetros de NMR usando células de sarcoma 
180 (S180). O completo assinalamento dos metabólitos de S180 é também apresentado para 
auxiliar estudos futuros.
High resolution magic angle spinning 1H nuclear magnetic resonance spectroscopy (HR-MAS 
NMR) is a useful technique for evaluation of intact cells and tissues. However, optimal NMR 
parameters are crucial in obtaining reliable results. To identify the key steps for the optimization 
of HR-MAS NMR parameters, we assessed different pulse sequences and NMR parameters using 
sarcoma 180 (S180) cells. A complete assignment of the metabolites of S180 is given to assist 
future studies.
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Introduction
Cancer is among the leading causes of death globally. 
It is well known that early diagnosis is crucial for effective 
treatment. The development of new techniques for detection 
of cancer prior to its progression has become an important 
challenge for the scientific community. High resolution 
magic angle spinning 1H nuclear magnetic resonance 
spectroscopy (HR-MAS NMR) offers the potential to 
distinguish tumor types and to investigate tissues, detecting 
metabolic profiles and consequently cell biomarkers.1 In 
recent years, studies of brain ,2,3 breast,4 colorectal,5 and 
lung tumors,6 among others, have confirmed HR-MAS 
NMR as a promising technique in cancer diagnosis. 
At the same time, with the arrival of the metabolomic 
era, many studies applying HR-MAS NMR have been 
undertaken to monitor metabolic changes in tumor cells. 
The assessment of changes in metabolic profile has been 
found especially useful in studying the efficacy and safety 
of new drugs or in monitoring disease progression for 
clinical purposes.7-11 Additionally, the use of HR-MAS 
NMR has other advantages, such as providing qualitative, 
quantitative and structural information, and detecting 
a wide range of metabolites simultaneously in a single 
spectrum. 
On the other hand, because of the great complexity 
of the cell matrix, several works have shown that 
minor variations of analyzed data make it important to 
discriminate differences in metabolism, demanding the 
application of statistical methods to obtain useful results. 
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To obtain good results and highly reproducible spectra, it 
is necessary to optimize NMR experiments before applying 
refined data analysis. Sample preparation, temperature 
and choice of pulse sequences must be optimized. For 
this reason, it is very important that NMR acquisition 
parameters are optimized to avoid distortion of the data, 
such as distortions in phase and baseline caused by 
incomplete water suppression.12-14
In this context, to develop a robust methodology and 
to establish a procedure for diagnostic 1H HR-MAS NMR, 
we assessed four pulse sequences. We also assessed the 
effects of variations in the acquisition parameters of CPMG 
(Carr-Purcell-Meiboom-Gill) pulse sequences. Studies 
employing NMR HR-MAS to evaluate cancer tissues 
frequently apply CPMG pulse sequences to suppress broad 
signals, which may overlap significant peaks of interest and 
make metabolomic analysis difficult.1 To our knowledge, 
no published study has discussed the optimization of the t 
and n parameters of the CPMG pulse sequence.
All NMR data were obtained at room temperature 
(23 ºC) using sarcoma 180 (S180) cells. S180 is a 
frequently studied murine tumor, an excellent model that 
is used especially for testing drug candidates with potential 
anticancer activity.15-17 Thus, this study was also intended 
to assist future work through the full assignment of S180 
metabolites. 
Materials and Methods
Animal-handling procedure and sample preparation 
Swiss mice aged 6-8 weeks and weighing 30-35 g were 
provided by the Central Animal Facility of UFG, and were 
maintained at the Laboratory of Experimental Oncology at 
the Department of General Biology, Institute of Biological 
Sciences I, at UFG, in ventilated racks EB275C model with 
3-5 animals per mini insulator, under controlled temperature 
(22 ± 3 °C) and light-dark cycle of 12 h room conditions. The 
animals were maintained on standard diet with commercial 
feed and water ad libitum. All experimental procedures were 
approved by the Ethics Committee on Animal Use of UFG, 
under protocol number 039/12.
Sarcoma 180 (S180) cells (ascitic murine sarcoma) 
were purchased from the ATCC cell bank. The cell line 
was maintained in mice by intraperitoneal inoculation; 
transplantation was performed every ten days. After tumor 
stimulation, mice were sacrificed by cervical dislocation 
under sterile conditions. Then, S180 cells were aspirated 
removed from the intraperitoneal cavity with a syringe, 
transferred to a Falcon tube and centrifuged for 10 minutes 
at 1500 rpm at room temperature.
The supernatant was discarded and the pellet resuspended 
in 5 mL of RPMI 1640 medium supplemented with 10% 
fetal bovine serum (FBS), treated with penicillin and 
streptomycin, and centrifuged again. Aliquots of the pellets 
(40 µL, equivalent to 5 × 105 cells) were inserted in the 
HR-MAS rotor with 10 µL of TMSP-d4/D2O (sodium-2,2,3,3-
d4-3-trimethylsilylpropionate in deuterium oxide, 0.1%).
Fresh S180 samples were obtained from five different 
mice according to the above procedure for comparison 
among replicates. A control sample (RPMI 1640 medium 
supplemented with 10% FBS in TMSP-d4/D2O) was 
evaluated to detect contaminants. 
1H HR-MAS NMR spectra
All 1H HR-MAS NMR measurements were carried 
out on a Bruker Avance III 500 instrument (operating at 
500.13 MHz) equipped with a 4 mm HR-MAS probe and 
50 µL zirconium rotor. TMSP-d4/D2O was used for lock 
and field homogeneity adjustment. Spectra were collected 
at 5 kHz spin rate with temperature held constant at 23 °C. 
Four different pulse sequences were tested. Two of 
these were common pulse sequences for water suppression 
using pre-saturation pulse (ZGPR) and composite pulse 
(ZGCPPR). A one-dimensional NOESY pulse sequence 
(NOESYPR1D) was also assessed (recycle delay-90-t1-
90-tm-90-acquisition, with t1 delay 3 µs and mixing time 
[tm] 100 ms). Finally, the CPMG spin-echo pulse sequence 
with pre-saturation (CPMGPR1D) was also evaluated. 
The CPMG pulse sequence is as follows: recycle delay 
– [–90º– (t – 180º – t )n – FID], recycle delay = 1.0 s [to 
allow T1 relaxation]; t = ‘variable’ [to permit broad signal 
attenuation (T2 filter) and refocusing of spin-coupled 
multiplets]; n = ‘variable’ [for a fixed loop cycle]. 
For application of the CMPGPR1D pulse sequence, 
arrays of t and n values were studied. With n fixed to 
128 cycles, a wide range of t values (100, 300, 500, 670, 
and 800 µs; 1.0, 1.3, 1.5, 1.7, 2.0, 2.5, 3.0, and 6.0 ms) 
was tested. The value of n was also varied (5, 20, 64, 128, 
256 cycles) with t fixed to 500 µs or 1.0 ms.
Typically, 1H NMR data were collected with 128 scans 
and 65,536 data points using a 6.7 ms pulse width (90º pulse 
angle) and a 3.27 s acquisition time with the same receiver 
gain. The total experiment time was about 30 minutes. 
Spectra of one sample were collected at various periods 
of time for 24 h and no obvious alterations were observed 
in the 1H CMPG HR-MAS NMR spectra of S180 cells in 
a period of approximately 4 h.
Prior to Fourier transformation (FT), FIDs were zero-filled 
and an exponential weighing factor corresponding to 0.3 Hz 
line broadening applied. The acquired NMR spectra were 
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phase-corrected and referenced using TMSP-d4 as internal 
reference. For metabolite assignment, gTOCSY and gCOSY 
experiments were carried out using default parameters.
Results 
Comparison of pulse sequences
Figure 1 shows the 1H HR-MAS NMR spectra of a fresh 
sample using: i) ZGPR; ii) ZGCPPR; iii) NOESYPR1D 
and iv) CPMGPR1D. Qualitative analysis revealed no 
evident changes in metabolite signals caused by the water 
suppression. 
The pulse sequences differed significantly in water 
signal attenuation. The quality of residual water suppression 
was good for ZGCPPR (Figure 1B) and CPMGPR1D 
(Figure 1D). However, both sequences caused distortions 
in the baseline around the water signal. It is clear that the 
suppression band for ZGPR (Figure 1A) was the broadest, 
although signal intensity was lower than NOESY1DPR 
(Figure 1C). 
Furthermore, detailed examination of ZGPR, ZGCPPR 
and NOESY1DPR spectra revealed broad metabolite 
signals, as shown in Figure 2. With a T2 filter in the 
CPMGPR1D acquisition sequence (Figure 2D), narrower 
lines were obtained, and a better visualization of S180 
metabolites achieved.
Therefore, a more detailed study of T2 filtering was 
undertaken to optimize the suppression of macromolecule 
signals, especially those from proteins. Firstly, an array of 
Figure 1 Expansion/Detail of H2O signal suppression from 1H HR-MAS NMR spectra (D2O, 500 MHz) of S180 cells using A) ZGPR, B) ZGCPPR, 
C) NOESY1DPR and D) CPMGPR1D pulse sequences.
Figure 2. Expansion/detail of S180 cell 1H HR-MAS NMR spectra (D2O, 500 MHz) comparing the resolution obtained using A) ZGPR, B) ZGCPPR, 
C) NOESY1DPR and D) CPMGPR1D pulse sequences.
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the delay (t) between 180º pulses was tested (100, 300, 500, 
670 and 800 µs; 1.0, 1.3, 1.5, 1.7, 2.0, 2.5, 3.0 and 6.0 ms) 
with n fixed at 128 cycles.
Seven different spectra are shown to the same scale 
in Figure 3, with echo times selected to show the most 
prominent differences. As seen in Figures 3A to 3C, 
extremely large values of t (greater than 2.0 ms) led to loss 
of the signal of interest or revealed signals with unsatisfactory 
intensities. On the other hand, very small values of t (500 and 
100 µs) did not suppress broad signals (Figures 3F and 3G). 
Thus, intermediate t values were optimal for acquisition 
of 1H HR-MAS NMR spectra, as shown in Figures 3D and 
3E. The signals of small molecules remained apparent; 
likewise, the broad signals of macromolecules were filtered 
at both t values (1.5 and 1.0 ms). The signal-to-noise ratio 
was better at t = 1.0 ms, mainly in the aromatic region; 
hence, this value was selected.
The number of cycles (n = 256, 128, 64, 20, 5) was 
also optimized. When smaller values of n were used, 
macromolecules gave broad and overlapping signals 
(Figures 4A, 4B and 4C), hiding potentially important signals 
from metabolites. As shown in Figure 4D, at n = 128 the 
signal-to-noise ratio was increased; furthermore, no broad 
signals from macromolecules were observed. By contrast, 
a larger value of n (Figure 4E) reduced spectral sensitivity.
The optimal experimental conditions for the 
CPMGPR1D pulse sequence were thus found to be t = 1 ms 
and n = 128, giving a total spin-spin relaxation delay (2nt) 
of 256 ms. This filtered broad signals without reducing the 
signal-to-noise ratio.
Assignment of S180 cell metabolites 
Comparison of high-resolution CPMG spectra with 
literature data18-24 and two dimensional proton-proton 
spectroscopy (gTOCSY and gCOSY – data not shown) 
between δ 0.5 and 8.5 allowed the identification and signal 
assignment of twenty different metabolites (Table 1). 
Figure 3. Expansion/detail of S180 cell 1H HR-MAS NMR spectra (D2O, 500 MHz) using a CPMGPR1D pulse sequence with different values of t: 
(A) 6.0 ms, (B) 2.5 ms, (C) 2.0 ms, (D) 1.5 ms, (E) 1.0 ms, (F) 500 µs and (G) 100 µs. The t values shown were selected to reveal the most prominent 
differences in the spectra. 
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Figure 4. Expansion/detail of S180 cell 1H HR-MAS NMR spectra (D2O, 500 MHz) using a CPMGPR1D pulse sequence with different numbers of 
cycles: (A) 5, (B) 20, (C) 64, (D) 128 and (E) 256 (t fixed to 1.0 ms). The n values were selected to reveal the most prominent differences in the spectra. 
Compounds, chemical shifts and assignments are shown 
in Figure 5 and Table 1.
Discussion
As typically found in cells and tissue samples, water 
gave a stronger signal in S180 cells than metabolites. This 
resonance must be suppressed to acquire high-quality NMR 
data, avoiding signal overlap and dynamic range problems. 
It is well known that NMR is a technique of low sensitivity. 
Reducing the water signal allows acquisition with the 
largest possible receiver gain. As a result, metabolites 
at low concentrations that may be important for profile 
discrimination can be detected. In addition, adequate water 
suppression allows the acquisition of reproducible spectra, 
which facilitates the use of statistical and quantitative 
techniques for metabolomic studies.
Several types of pulse sequence are available for 
suppression of water signals. In particular, Chen and co-
authors13,14 describe pulse sequences for water suppression 
in HR-MAS experiments on cells and tissues. They show 
that the strong coupling of membrane lipids to water 
inherent to HR-MAS NMR makes water suppression 
difficult. Thus, it is necessary to develop methods enabling 
efficient water suppression for intact cells and tissue 
samples without also suppressing metabolite signals.13,14 In 
this work, we tested four pulse sequences for this purpose. 
Although all the tested pre-saturation and composite pulse 
sequences successfully removed the water signal, the 
ZGCPPR and CPMGPR1D sequences gave the best results 
(Figure 1). Under optimal conditions, the residual water 
signal was narrowed and suppressed without perturbing 
other signals or the baseline.
Another factor taken into consideration was the need 
for a clear spectrum with good visualization of metabolite 
resonances because this can be used to characterize the 
cell’s metabolite profile. Because macromolecules are 
inevitably found in biological matrices, the spectral 
resolution and analysis of signals may be dramatically 
affected by their broad resonances. Thus, the choice of 
pulse sequence to optimize spectral resolution is very 
important.
Although the water signal was narrowed by the chosen 
acquisition sequences, the removal of signals from large 
molecules with short transverse relaxation times improved 
the resolution of the peaks from significant metabolites, 
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especially those between 2.0 to 3.0 ppm and 6.5 to 
8.5 ppm (Figure 2). In fact, application of a T2 filter in the 
CPMGPR1D sequence facilitated the evaluation of cell 
metabolic profile.
Given that CPMGPR1D showed better-resolved 
signals because of its T2 filter, the optimization of t and n 
values permitted improvement of spectral quality. To our 
knowledge, the optimization of 2tn values of the T2 filter 
in CPMG pulse sequence applied to cell samples has not 
been reported previously. 
Although small molecules have large transverse 
relaxation times, very large values of t (greater than 2.0 ms, 
Figures 3A to 3C) permitted transverse relaxation for both 
types of molecule (small and macro-). Thus, large values 
of t should be avoided. 
Table 1. Chemical shift assignments for metabolites from 1H HR-MAS NMR spectra of S180 cells (D2O, 500 MHz)
Assigned number Metabolite Multiplicity J / Hz d / ppm

























































7 Alanine βCH3 d 7.21 1.49
αCH q 7.21 3.78
8 Acetate CH3 s - 1.93
9 Glutamate βCH2 m c 2.09
γCH2 m c 2.36









12 Choline N(CH3)3 s - 3.21
13 Phosphocholine N(CH3)3 s - 3.23
14 Glycerophosphocholine N(CH3)3 s - 3.24
15 Taurine N-CH2 t 6.66 3.28
S-CH2 t 6.66 3.44


























Chemical shifts are referenced relative to TMSP-d4. Abbreviations – s: singlet, d: doublet, t: triplet, q: quartet, m: multiplet, c: coupling constant not 
determined. Compound numbers correspond to those in Figure 5.
In contrast, when t values were lower than T2 for 
macromolecules, the broad signals overlapped the 
signals of low molecular weight metabolites. Therefore, 
intermediate values of t (Figures 3D and 3E) ensured 
that macromolecules were properly filtered without the 
disappearance of small molecules. When the t value was 
1.0 ms (Figure 3E), the signal/noise ratio was better than 
1.5 ms (noise was slightly superior). We therefore suggest 
that a value of 1.0 ms should be used in future studies with 
S180 cells. 
For optimization of the number of cycle loops (n), even 
when the t value was optimal, smaller values of n masked 
metabolite signals because the macromolecules did not 
relax completely by T2, appearing in the spectra as broad 
resonances (Figures 4A, B and C). 
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tumor types. For instance, it has been reported that choline 
derivates are associated with accelerated cell proliferation; 
as precursors of phospholipid membranes, they can be used 
as cell proliferation biomarkers.25-27
Conclusion
This work has addressed a number of important 
problems regarding the practical application of HR- 
MAS NMR spectroscopy to the study of S180 cells. The 
optimal experimental conditions for the CPMGPR1D pulse 
sequence were found to be t = 1 ms and n = 128 cycles, 
giving a total spin-spin relaxation delay (2nt) of 256 ms. 
Sensitivity and resolution, and consequently the quality of 
spectra obtained from S180 cells, were improved by the 
optimized pulse sequence.
Using the optimized HR-MAS NMR experiment, the 
assignment of twenty different metabolites was possible. 
This information may be a guide for metabolomic research 
using the HR-MAS NMR technique in S180 cells because 
it provides the chemical profile of these cells. 
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Figure 5. 1H HR-MAS NMR spectrum of S180 cells (D2O, 500 MHz) with spectral assignments of metabolites numbered (see Table 1 for numbering).
In Figure 4D, at n = 128 the signal-to-noise ratio 
increased and no interfering broad signals from 
macromolecules were observed. This n value led to an 
enhancement in resolution and sensitivity; the signals 
that were reduced by this method had low intensity and 
appeared as an elevation of the baseline overlapping the 
signals of small molecules.
A larger value of n (Figure 4E) decreased spectral 
sensitivity because small molecules were also T2-filtered. 
This value also increased total analysis time.
For these reasons, in NMR analyses of cells and tissues 
using the CPMG pulse sequence, t values should be kept 
low and the number of cycles (n) should be increased 
appropriately to increase total T2 relaxation delay. 
Moreover, it is important to highlight that t and n 
parameters are directly related, and therefore each value 
of t will present an optimal value of n. Then, for t = 1 ms, 
n = 128 cycles is the optimal experimental conditions for 
the CPMGPR1D pulse sequence.
A complete assignment of metabolite profile was 
obtained, which should be of value in future work with S180 
cells. Most of these metabolites are composed of amino 
acids and membrane components such as lipids and choline 
derivatives. This systematic analysis is appealing because 
it has been shown in cellular models that these resonances 
may act as cell proliferation markers.25 Thus, they may 
provide additional information for discrimination of 
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